A geniuine opportunity to be part of a team at a leading private cancer treatment centre at the forefront of cancer care, working in a team of oncology specialists to develop a personalised private patient treatment plan, tailored towards p...
An exciting opportunity is available for a Resident Doctor to care for patients with haematological malignancies and deliver high standards of medical care for both inpatients and outpatients attending the day case unit. The sucessful candi...
which delivers world-class live events and outstanding digital content to markets across 30 countries. From Biotech and Pharma to pop... decision makers that produces world class content, conferences and events for C-suite executives, investors and pharma, medtech...
Full Stack Developer - C#, .NET & Angular Global Pharma Tech Software Company based in Brighton, Sussex (hybrid 2/3... days a week in the office) Up to 65K DOE plus bens and bonus. My client is a global pharma tech company working right...
We are an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, colour, religion, sex, national origin, disability status, protected veteran status, or any other characteri...
Brent crude and US WTI had had dropped by more than a dollar early in the session on easing tensions between Israel and Iran, along with nagging concerns on demand from top oil importer China. Continue Reading »
Gold prices today: Spot gold fell 0.3 per cent to $2,318.90 per ounce after earlier hitting its lowest since April 5. Bullion's March to April rally drove it up by $400 to an all-time high of $2,431.29 on April 12. Continue Reading »
Swedish company Spotify Technology SA, listed on the NYSE, was trading at $311.01, higher $38.77, or 14.24 per cent, at 11:47 a.m. EDT Continue Reading »
Tesla shares have dropped more than 40 per cent year-to-date as Elon Musk's EV giant has struggled with layoffs and product discounts in the last few months Continue Reading »
JNK India IPO opened for subscription on April 23, closing on April 25. The issue was subscribed to 49% on the first day, with significant participation from QIBs. Key risks outlined in the company's Red-Herring Prospectus include market volatility, regulatory changes, and competition. Continue Reading »